This company selected Vertex in part due to Systax as they have extensive operations in Brazil. In addition, we had a strong ...

Vertex Companies is a content partner of Bisnow and have worked with our Studio B team to develop creative content and custom offerings. VERTEX’S LONG-TERM SUCCESS IS BASED ON ADHERENCE TO A ...

Analyst Joshua Reilly of Needham maintained a Buy rating on Vertex (VERX – Research Report), boosting the price target to $60.00. Joshua ...

Vertex also reported a steady increase in its R&D and SG&A expenses, reflecting its aggressive investment in pipeline ...

Vertex Pharmaceuticals has agreed to acquire Alpine Immune Sciences for $4.9 billion in cash, bolstering its portfolio on ...

Vertex Pharmaceuticals again raised its full-year outlook after posting earnings and revenue growth in the third quarter. The biotechnology company on Monday posted a quarterly net profit of $1.05 ...

Micron announced changes to its Board of Directors on Wednesday. Micron said Robert (Bob) Switz, its current Board Chair, ...

Vertex may have pivoted away from the space, but candidates in development by Arrowhead/Takeda, Wave, Korro and others could ...

Good day, and welcome to the Vertex Pharmaceuticals third quarter 2024 earnings call. All participants will be in a ...

Moderna and Vertex Pharmaceuticals, two of the biggest biotechnology companies in Massachusetts by head count, will together receive more than $11 million in tax breaks from the state in exchange ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Glaukos (GKOS – Research Report) and Vertex Pharmaceuticals (VRTX – Research Report) with bullish ...

Nineteen companies are receiving $21.4 million total in tax incentive awards to create 1,155 new life sciences jobs in Massachusetts. Moderna and Vertex received the largest awards and will add over ...